Archives
EZ Cap™ mCherry mRNA (5mCTP, ψUTP): Advanced Red Fluoresc...
EZ Cap™ mCherry mRNA (5mCTP, ψUTP): Advanced Red Fluorescent Reporter Gene mRNA
Executive Summary: EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is a synthetic messenger RNA encoding the monomeric red fluorescent protein mCherry, derived from Discosoma's DsRed protein and measuring approximately 996 nucleotides in length. The product features a Cap 1 structure, enzymatically added to mimic mammalian mRNA, which improves translation efficiency and reduces innate immune recognition (Guri-Lamce et al., 2024). Modified nucleotides 5-methylcytidine triphosphate (5mCTP) and pseudouridine triphosphate (ψUTP) further suppress RNA-mediated immune activation and extend mRNA stability. Provided at ~1 mg/mL in 1 mM sodium citrate buffer (pH 6.4), it is intended as a high-performance reporter gene for fluorescent imaging and molecular tracking in cell biology (ApexBio R1017).
Biological Rationale
Reporter gene mRNAs are essential tools for monitoring gene expression, protein localization, and cellular processes. mCherry is a red fluorescent protein with excitation and emission maxima at ~587 nm and ~610 nm, respectively, allowing robust detection in complex biological samples (Site Article). Synthetic mRNAs with modified nucleotides and optimized caps can evade immune detection, increase translation, and prolong protein expression in mammalian cells (Guri-Lamce et al., 2024). Cap 1-structured mRNAs closely resemble endogenous eukaryotic transcripts and facilitate efficient ribosome engagement. The inclusion of a poly(A) tail further enhances translation initiation and mRNA stability (Biotin.mobi).
Mechanism of Action of EZ Cap™ mCherry mRNA (5mCTP, ψUTP)
- Cap 1 Structure: The 5' Cap 1 is enzymatically added using Vaccinia virus Capping Enzyme (VCE), GTP, S-adenosylmethionine (SAM), and 2'-O-Methyltransferase. This cap structure is recognized by mammalian translational machinery and reduces innate immune activation by RIG-I and MDA5 sensors (Guri-Lamce et al., 2024).
- Modified Nucleotides: Incorporation of 5mCTP and ψUTP into the mRNA backbone diminishes recognition by Toll-like receptors (TLR7/8) and other innate immune pathways, reducing inflammatory cytokine induction and improving in vivo translation efficiency (PrecisionFDA.net).
- Poly(A) Tail: An enzymatically added poly(A) tail promotes mRNA stability and translation efficiency by facilitating poly(A)-binding protein (PABP) interactions and shielding the mRNA from exonuclease degradation.
- Formulation and Storage: The mRNA is provided at ~1 mg/mL in 1 mM sodium citrate (pH 6.4) and should be stored at or below -40°C to maintain structural integrity and biological activity (ApexBio R1017).
Evidence & Benchmarks
- Cap 1-modified mRNAs exhibit significantly reduced innate immune activation compared to uncapped or Cap 0 mRNAs in primary mammalian cells (Guri-Lamce et al., 2024, DOI).
- 5mCTP/ψUTP modifications increase mRNA half-life by up to 2–3 fold in vitro and in vivo models relative to unmodified mRNAs (PrecisionFDA.net, site article).
- mCherry protein expressed from synthetic mRNA produces bright, stable fluorescence with excitation at 587 nm and emission at 610 nm under standard cell culture conditions (Applied Strategies, site article).
- Lipid nanoparticle (LNP) delivery systems efficiently transfect Cap 1-mRNA constructs, with high expression and minimal cytotoxicity (Guri-Lamce et al., 2024, DOI).
- Optimized storage (≤ -40°C) prevents mRNA degradation for at least 12 months (ApexBio R1017, product page).
Applications, Limits & Misconceptions
- Live Cell Imaging: Enables real-time tracking of gene expression and protein localization in live cells due to robust mCherry fluorescence.
- Reporter Gene Assays: Serves as a sensitive molecular marker for transfection efficiency and promoter activity experiments.
- Immune Evasion Studies: Suits immunology workflows requiring minimal interferon response or background activation, owing to nucleotide modifications (SM-102.com).
- Cellular Localization: Facilitates visualization of subcellular compartments when fused with targeting sequences.
Common Pitfalls or Misconceptions
- Not a Therapeutic: This product is for research use only; it is not validated for clinical therapy or diagnostic purposes.
- Requires Proper Delivery: Direct addition to cell culture is ineffective; mRNA must be delivered with lipid nanoparticles or electroporation for optimal uptake.
- Not Suitable for Long-Term Stable Expression: Expression persists for hours to days, not weeks; it cannot substitute for stable genomic integration.
- Temperature Sensitivity: Storage above -40°C can cause rapid degradation and loss of fluorescence.
- Limited Spectral Range: mCherry fluorescence is not suitable for experiments requiring emission outside the 610 nm window.
Workflow Integration & Parameters
- Preparation: Thaw EZ Cap™ mCherry mRNA (5mCTP, ψUTP) on ice. Avoid freeze-thaw cycles.
- Transfection: Use lipid-based reagents (e.g., MessengerMAX) or electroporation for high-efficiency delivery. Optimal mRNA concentration: 0.1–2 μg per 106 cells.
- Detection: Fluorescence is detectable 2–4 hours post-transfection, peaking at 12–24 hours.
- Controls: Include mock and unmodified mRNA controls to benchmark immune response and expression efficiency.
- Storage: Store aliquots at ≤ -40°C in RNase-free conditions.
This article expands on previous summaries by providing a structured, evidence-linked mechanistic and application-focused guide for practitioners. It also clarifies workflow parameters not addressed in mechanistic reviews and updates recent performance benchmarks discussed in competitive analyses.
Conclusion & Outlook
EZ Cap™ mCherry mRNA (5mCTP, ψUTP) sets a new standard for reporter gene mRNAs, combining Cap 1 capping, nucleotide modification, and polyadenylation for high-fidelity fluorescent protein expression. Its design enables robust, immune-evasive, and stable protein production, supporting advanced molecular imaging and cell tracking workflows. As mRNA delivery and design technologies progress, such products will underpin next-generation research in genomics, cell biology, and translational medicine. For technical details and purchasing, see the EZ Cap™ mCherry mRNA (5mCTP, ψUTP) product page.